Cav3 inhibitors (Cavion)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug NameCav3 inhibitors (Cavion)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated T-type calcium channel blockers
TargetsVoltage-gated T-type calcium channel
Therapy Area/IndicationsNervous System DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCavion Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCavion Inc
Active IndicationsN/A
Inactive IndicationsNervous System DiseasesNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A